|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 12:30PM
|
|
Re: Question for the board!
|
2
|
Zenith Epigenetics
|
Jan 22, 2019 12:46PM
|
|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 02:24PM
|
|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 05:56PM
|
|
Re: Outstanding shares
|
1
|
Resverlogix Corp.
|
Jan 23, 2019 12:32PM
|
|
Alzheimers and Epigenetics!
|
1
|
Resverlogix Corp.
|
Jan 24, 2019 11:10AM
|
|
Re: Alzheimers and Epigenetics!
|
1
|
Resverlogix Corp.
|
Jan 24, 2019 11:53AM
|
|
Re: The waiting game.....Jan 30th = max pain :-)
|
2
|
Resverlogix Corp.
|
Jan 24, 2019 07:08PM
|
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
5
|
Resverlogix Corp.
|
Jan 28, 2019 09:23AM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 08:48AM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
1
|
Resverlogix Corp.
|
Jan 29, 2019 01:55PM
|
|
Re: Adjudication
|
1
|
Resverlogix Corp.
|
Jan 29, 2019 07:32PM
|
|
Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 29, 2019 07:42PM
|
|
Interesting !
|
1
|
Resverlogix Corp.
|
Jan 30, 2019 11:17AM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 05:06PM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 04:11PM
|
|
Re: Sent this to Sarah this morning
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 04:14PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
4
|
Resverlogix Corp.
|
Jan 31, 2019 10:11PM
|
|
Re: Setting expectations....
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 07:40AM
|
|
Re: You're right 10bagr, you didn't sway me....
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 09:27AM
|
